| |||||||||||||||||||||||||||||||||||
# of Animals | Phenotype | Strain | Sex | Value | Units | Conditions | Record ID | ||||||||||||||||||||||||||||
14 | maximum body weight loss to initial body weight ratio | DA.PVG.1AV1-(D4Rat155-D4Rat84) | both | 5.9 | % | Freund's complete adjuvant (100 ul) | 69797 | Freund's complete adjuvant (100 ul) | |||||||||||||||||||||||||||
14 | percentage of study population developing experimental arthritis during a period of time | DA.PVG.1AV1-(D4Rat155-D4Rat84) | both | 36 | % | Freund's complete adjuvant (100 ul) | 69708 | Freund's complete adjuvant (100 ul) | |||||||||||||||||||||||||||
14 | post-insult time to onset of experimental arthritis | DA.PVG.1AV1-(D4Rat155-D4Rat84) | both | 13.6 | d | Freund's complete adjuvant (100 ul) | 69776 | Freund's complete adjuvant (100 ul) | |||||||||||||||||||||||||||
14 | serum orosomucoid 1 level | DA.PVG.1AV1-(D4Rat155-D4Rat84) | both | 370 | mg/l | Freund's complete adjuvant (100 ul) | 69755 | Freund's complete adjuvant (100 ul) |